All Scientific Activities

DNA repair

Based on the established role of mutations in cancer, and the importance of oxidative stress in creating the environment in which mutations occur, Prof. Zvi Livneh and Dr. Tamar Paz-Elizurof the Department of Biomolecular Sciences are exploring the role that non-optimal repair of oxidative DNA damage plays in colorectal and breast cancer onset. Using an integrated approach that combines epidemiological and clinical studies, the researchers have created a unique set of DNA repair blood tests that help characterize the molecular environment, and correlate this data with known risk factors for breast and colorectal cancer. Using this approach, they hope to lay the groundwork for early detection strategies.

Community and collaboration

On December 7th, 2016, the Swiss Society Institute for Cancer Prevention Research, a division of the Moross Integrated Cancer Center (MICC) at the Weizmann Institute of Science hosted a talk by Prof. Avrum Spira.  Prof. Spira, Director of the Boston Medical Center Cancer Center of Boston University, spoke about “the airway transcriptome as a biomarker for lung cancer detection and prevention.” In his lecture, Prof. Spira described techniques he and his team have developed for the identification of gene-expression-based biomarkers that can contribute to the personalized care of patients with lung cancer, as well as chronic obstructive pulmonary disease (COPD).

Eliminating flaws

Lymphocytes are cells in our immune system that work as sentinels, identifying and eliminating flawed cells, including those that have been transformed into a pre-cancerous state.  Researchers at the Swiss Society Institute for Cancer Prevention Research are examining new avenues towards the characterization of this “surveillance” function, in order to eventually adopt this functionality in preventative therapeutics for high-risk patients.

Programmed cell death

When the body identifies flawed cells, programmed cell death kicks in and prevents their proliferation.  Dysregulationof this process–also called apoptosis–can lead to cancer onset. Dr. Valery Krizhanovsky, of the Department of Molecular Cell Biology, is examining one apoptotic process called senescence, in which flawed cells are left to live, but cannot proliferate. While a senescent state, which can occur in response to cancer-inducing mutations, serves as an initial barrier to tumor development, the presence of non-dividing, senescent cells is also linked to inflammation, tissue destruction, tumorigenesis and metastasis. Using a small molecule, Dr. Krizhanovsky has demonstrated that it is possible to target and trigger apoptosis in senescent cells.  Working in a model of pancreatic cancer, his team’s work is contributing to new strategies that may eliminate senescent cells, and thus prevent the progress of pancreatic cancer to its more advanced stages.

Identifying risk factors

Extensive studies have established a causal link between smoking and cancer. While the danger of smoking is now well known, the general public is less aware of cancer-related risk factors stemming from air pollution. This is one area of research being pursued by Prof. Yinon Rudich of the Department of Earth and Planetary Sciences.

Read More about Identifying risk factors

Robot-assisted tests

Translational research is essential in moving basic research discoveries from the lab to the public health arena, and tissue samplesare a necessary and precious resource for these studies.

Blood is a common tissue often used in translational and medical research. Peripheral Blood Mononuclear Cells or PBMC (composed primarily of lymphocytes) are isolated by fractionation in Ficoll tubes.

Read More about Robot-assisted tests